LAUREN P. SILVERNAIL

Insider Reports History

Location
Irvine, CA
Signature
Lauren Silvernail, by /s/ Trevor Dutcher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LAUREN P. SILVERNAIL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Evolus, Inc. Chief Financial Officer and Executive Vice President, Corporate Development Common Stock 141,571 $1,377,288 $9.73 18 May 2022 Direct
DYNAVAX TECHNOLOGIES CORP Director Common Stock 10,075 $97,929 $9.72 11 Jun 2025 Direct
HARROW, INC. Director RSU 7,339 20 Jun 2025 Direct
DYNAVAX TECHNOLOGIES CORP Director Common Stock - Restricted Stock Units 0 10 Feb 2026 Direct
DYNAVAX TECHNOLOGIES CORP Director Stock Option (Right to Buy) 0 10 Feb 2026 Direct
Harpoon Therapeutics, Inc. Director Common Stock 0 11 Mar 2024 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 0 11 Mar 2024 Direct

Insider Reports Filed by LAUREN P. SILVERNAIL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DVAX DYNAVAX TECHNOLOGIES CORP 10 Feb 2026 3 $0 4 Director 10 Feb 2026, 16:15
HROW HARROW, INC. 20 Jun 2025 1 $0 4 Director 24 Jun 2025, 18:53
DVAX DYNAVAX TECHNOLOGIES CORP 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 17:55
DVAX DYNAVAX TECHNOLOGIES CORP 03 Feb 2025 2 $0 4 Director 05 Feb 2025, 18:29
DVAX DYNAVAX TECHNOLOGIES CORP 03 Feb 2025 0 $0 3 Director 05 Feb 2025, 18:28
HROW HARROW, INC. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 18:00
/report/000095017024029447-silvernail-lauren-p-2024-03-11 Harpoon Therapeutics, Inc. 11 Mar 2024 3 $0 4 Director 11 Mar 2024, 17:26
HROW HARROW, INC. 26 Jan 2024 1 $0 4 Director 30 Jan 2024, 16:10
HROW HARROW, INC. 26 Jan 2024 0 $0 3 Director 30 Jan 2024, 16:05
/report/000120919123056799-silvernail-lauren-p-2023-11-27 Harpoon Therapeutics, Inc. 27 Nov 2023 1 $0 4 Director 28 Nov 2023, 16:29
/report/000120919123039424-silvernail-lauren-p-2023-06-22 Harpoon Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:40
/report/000120919122050515-silvernail-lauren-p-2022-09-15 Harpoon Therapeutics, Inc. 15 Sep 2022 1 $0 4 Director 19 Sep 2022, 16:23
/report/000120919122050506-silvernail-lauren-p-2022-09-15 Harpoon Therapeutics, Inc. 15 Sep 2022 0 $0 3 Director 19 Sep 2022, 16:17
EOLS Evolus, Inc. 17 May 2022 2 -$871,380 4 Chief Financial Officer and Executive Vice President, Corporate Development 18 May 2022, 20:21
EOLS Evolus, Inc. 08 Mar 2022 1 -$99,121 4 Chief Financial Officer and Executive Vice President, Corporate Development 10 Mar 2022, 18:23
EOLS Evolus, Inc. 24 Jan 2022 2 $0 4 Chief Financial Officer and Executive Vice President, Corporate Development 26 Jan 2022, 20:03
EOLS Evolus, Inc. 10 Aug 2021 1 -$159,774 4/A Chief Financial Officer and Executive Vice President, Corporate Development 12 Aug 2021, 19:05